Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric)

被引:54
作者
Bretonniere, Cedric [1 ,3 ]
Leone, Marc [2 ]
Milesi, Christophe [4 ]
Allaouchiche, Bernard [5 ]
Armand-Lefevre, Laurence [6 ]
Baldesi, Olivier [7 ]
Bouadma, Lila [8 ]
Decre, Dominique [9 ]
Figueiredo, Samy [10 ,11 ,31 ]
Gauzit, Remy [12 ]
Guery, Benoit [13 ]
Joram, Nicolas [14 ]
Jung, Boris [15 ,16 ]
Lasocki, Sigismond [17 ,29 ]
Lepape, Alain [18 ]
Lesage, Fabrice [19 ]
Pajot, Olivier [20 ]
Philippart, Francois [21 ]
Souweine, Bertrand [22 ]
Tattevin, Pierre [23 ]
Timsit, Jean-Francois [8 ,24 ]
Vialet, Renaud [25 ]
Zahar, Jean Ralph [26 ]
Misset, Benoit [27 ,28 ]
Bedos, Jean-Pierre [30 ]
机构
[1] CHU Immeuble Jean Monnet, Pole Hosp Univ 3, Reanimat Med Polyvalente, F-44093 Nantes, France
[2] Aix Marseille Univ, Hop Nord, Assistance Publ Hop Marseille, Serv Anesthesie & Reanimat, Marseille, France
[3] Univ Nantes, Therapeut Clin & Expt Infect EA3826, F-44035 Nantes, France
[4] Hop Arnaud de Villeneuve, Serv Reanimat Pediat, F-34296 Montpellier, France
[5] Hop Hotel Dieu, Dept Intens Care, F-69288 Lyon, France
[6] Grp Hosp Bichat Claude Bernard, AP HP, Serv Bacteriol, F-75877 Paris 18, France
[7] Ctr Hosp Intercommunal Aix Pertuis, Aix En Provence, France
[8] Hop Bichat Claude Bernard, AP HP, Reanimat Med & Malad Infect, F-75018 Paris, France
[9] St Antoine Hosp, AP HP, Microbiol, Paris, France
[10] Hop Bicetre, AP HP, Dept Anesthesie Reanimat, K Bicetre, France
[11] Univ Paris 11, Fac Med, Orsay, France
[12] Cochin Univ Hosp, Infect Dis & Intens Care Unit, F-75014 Paris, France
[13] Hop Huriez, Serv Gest Risque Infect Vigilances & Infectiol, F-59045 Lille, France
[14] CHU Nantes HME, Pole Hosp Univ 5, Reanimat Pediat, F-44093 Nantes, France
[15] St Eloi Teaching Hosp, Dept Crit Care Med & Anesthesiol, Montpellier, France
[16] CNRS 9214, INSERM, U1046, Montpellier, France
[17] Univ Montpellier, F-34059 Montpellier, France
[18] Univ Hosp Lyon Sud, Intens Care Unit, Pierre Benite, France
[19] Hop Necker Enfants Malad, AP HP, Hop Necker Enfants Malad Reanimat Pediat, F-75015 Paris, France
[20] Victor Dupouy Hosp, Intens Care Unit, F-95100 Argenteuil, France
[21] Grp Hosp Paris St Joseph, Med Surg ICU, Paris, France
[22] Univ Hosp Clermont Ferrand, Med Intens Care Unit, Clermont Ferrand, France
[23] Pontchaillou Univ Hosp, Infect Dis & Intens Care Unit, F-35033 Rennes, France
[24] Univ Paris Diderot, Sorbonne Paris Cite, INSERM,UMR 1137, IAME Team 5,Decis Sci Infect Dis Control & Care, F-75018 Paris, France
[25] Marseilles Univ Hosp Syst, Dept Anesthesia & Intens Care, F-13915 Marseilles, France
[26] Univ Angers, CHU Angers, Unite Prevent & Lutte Infect Nosocomiales, F-49000 Angers, France
[27] Grp Hosp Paris St Joseph, Ctr Rech Clin, Serv Med Intens & Reanimat, Paris, France
[28] Univ Paris 05, Paris, France
[29] CHU Angers, Dept Anesthesie Reanimat, Angers, France
[30] Ctr Hosp Versailles, Hop Andre Mignot, Reanimat, F-78157 Le Chesnay, France
[31] Univ Paris 11, INSERM, Emerging Resistance Antibiot U914, F-91405 Orsay, France
关键词
Antimicrobial stewardship; Epidemiology; Microbiological diagnostic techniques; Pharmacokinetics/pharmacodynamics; Therapeutic drug monitoring; VENTILATOR-ASSOCIATED PNEUMONIA; RESISTANT STAPHYLOCOCCUS-AUREUS; CRITICALLY-ILL PATIENTS; SEVERE SEPSIS STILL; DE-ESCALATION; ANTIMICROBIAL RESISTANCE; RISK-FACTORS; BRONCHOALVEOLAR LAVAGE; HOSPITALIZED-PATIENTS; INFECTIOUS-DISEASES;
D O I
10.1007/s00134-015-3853-7
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Emerging resistance to antibiotics shows no signs of decline. At the same time, few new antibacterials are being discovered. There is a worldwide recognition regarding the danger of this situation. The urgency of the situation and the conviction that practices should change led the Soci,t, de R,animation de Langue Fran double dagger aise (SRLF) and the Soci,t, Fran double dagger aise d'Anesth,sie et de R,animation (SFAR) to set up a panel of experts from various disciplines. These experts met for the first time at the end of 2012 and have since met regularly to issue the following 67 recommendations, according to the rigorous GRADE methodology. Five fields were explored: i) the link between the resistance of bacteria and the use of antibiotics in intensive care; ii) which microbiological data and how to use them to reduce antibiotic consumption; iii) how should antibiotic therapy be chosen to limit consumption of antibiotics; iv) how can antibiotic administration be optimized; v) review and duration of antibiotic treatments. In each institution, the appropriation of these recommendations should arouse multidisciplinary discussions resulting in better knowledge of local epidemiology, rate of antibiotic use, and finally protocols for improving the stewardship of antibiotics. These efforts should contribute to limit the emergence of resistant bacteria.
引用
收藏
页码:1181 / 1196
页数:16
相关论文
共 97 条
[1]   Continuous beta-lactam infusion in critically ill patients: the clinical evidence [J].
Abdul-Aziz, Mohd H. ;
Dulhunty, Joel M. ;
Bellomo, Rinaldo ;
Lipman, Jeffrey ;
Roberts, Jason A. .
ANNALS OF INTENSIVE CARE, 2012, 2
[2]   Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations [J].
Andes, D ;
Craig, WA .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 :10-17
[3]  
[Anonymous], 2014, ANT RES GLOB REP SUR, P256
[4]   Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients [J].
Armand-Lefevre, Laurence ;
Angebault, Cecile ;
Barbier, Francois ;
Hamelet, Emilie ;
Defrance, Gilles ;
Ruppe, Etienne ;
Bronchard, Regis ;
Lepeule, Raphael ;
Lucet, Jean-Christophe ;
El Mniai, Assiya ;
Wolff, Michel ;
Montravers, Philippe ;
Plesiat, Patrick ;
Andremont, Antoine .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (03) :1488-1495
[5]   Impact of restricting fluoroquinolone prescription on bacterial, resistance in an intensive care unit [J].
Aubert, G ;
Carricajo, A ;
Vautrin, AC ;
Guyomarc'h, S ;
Fonsale, N ;
Page, D ;
Brunel, P ;
Rusch, P ;
Zéni, F .
JOURNAL OF HOSPITAL INFECTION, 2005, 59 (02) :83-89
[6]   Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria [J].
Bassetti, Matteo ;
De Waele, Jan J. ;
Eggimann, Philippe ;
Garnacho-Montero, Jose ;
Kahlmeter, Gunnar ;
Menichetti, Francesco ;
Nicolau, David P. ;
Paiva, Jose Arturo ;
Tumbarello, Mario ;
Welte, Tobias ;
Wilcox, Mark ;
Zahar, Jean Ralph ;
Poulakou, Garyphallia .
INTENSIVE CARE MEDICINE, 2015, 41 (05) :776-795
[7]   New antibiotics for bad bugs: where are we? [J].
Bassetti, Matteo ;
Merelli, Maria ;
Temperoni, Chiara ;
Astilean, Augusta .
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2013, 12
[8]   Burden of infection in patients with end-stage renal disease requiring long-term dialysis [J].
Berman, SJ ;
Johnson, EW ;
Nakatsu, C ;
Alkan, M ;
Chen, RD ;
LeDuc, J .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (12) :1747-1753
[9]   Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial [J].
Bouadma, Lila ;
Luyt, Charles-Edouard ;
Tubach, Florence ;
Cracco, Christophe ;
Alvarez, Antonio ;
Schwebel, Carole ;
Schortgen, Frederique ;
Lasocki, Sigismond ;
Veber, Benoit ;
Dehoux, Monique ;
Bernard, Maguy ;
Pasquet, Blandine ;
Regnier, Bernard ;
Brun-Buisson, Christian ;
Chastre, Jean ;
Wolff, Michel .
LANCET, 2010, 375 (9713) :463-474
[10]   Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America [J].
Boucher, Helen W. ;
Talbot, George H. ;
Bradley, John S. ;
Edwards, John E., Jr. ;
Gilbert, David ;
Rice, Louis B. ;
Scheld, Michael ;
Spellberg, Brad ;
Bartlett, John .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) :1-12